Publications by authors named "Hui-May Chu"

Claim this Profile
A
Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies.
John J Alam, Paul Maruff, Susan R Doctrow, Hui-May Chu, Jennifer Conway

Neurology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration.
Ying Jiang, John J Alam, Stephen N Gomperts, Paul Maruff, Afina W Lemstra, Hui-May Chu

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease.
Niels D Prins, John E Harrison, Hui-May Chu, Kelly Blackburn, John J Alam

Alzheimers Res Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacometrics of clobazam in pediatrics: Prediction of effective clobazam doses for Dravet syndrome.
Dwain Tolbert, Hui-May Chu, Ene I Ette

Epilepsy Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning.
Michael S Manak, Jonathan S Varsanik, Brad J Hogan, Matt J Whitfield, Wendell R Su, Hui-May Chu

Nat Biomed Eng· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory clinical study of p38 kinase inhibition in Alzheimer's disease.
Philip Scheltens, Niels Prins, Adriaan Lammertsma, Maqsood Yaqub, Alida Gouw, Hui-May Chu

Ann Clin Transl Neurol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-metabolism mechanism: Knowledge-based population pharmacokinetic approach for characterizing clobazam drug-drug interactions.
Dwain Tolbert, Ihor Bekersky, Hui-May Chu, Ene I Ette

J Clin Pharmacol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrative population pharmacokinetics approach to the characterization of the effect of hepatic impairment on clobazam pharmacokinetics.
Dwain Tolbert, Ihor Bekersky, Hui-May Chu, Ene I Ette

J Clin Pharmacol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of resistant Val36 variants of hepatitis C virus NS3-4A serine protease.
Yi Zhou, Doug J Bartels, Brian L Hanzelka, Ute Müh, Yunyi Wei, Hui-May Chu

Antimicrob Agents Chemother· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.
Nicole Forestier, Hendrik W Reesink, Christine J Weegink, Lindsay McNair, Tara L Kieffer, Hui-May Chu

Hepatology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.
Christoph Sarrazin, Tara L Kieffer, Doug Bartels, Brian Hanzelka, Ute Müh, Hui-May Chu

Gastroenterology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A random sampling approach for robust estimation of tissue-to-plasma ratio from extremely sparse data.
Hui-May Chu, Ene I Ette

AAPS J· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data supplementation: a pharmacokinetic/pharmacodynamic knowledge creation approach for characterizing an unexplored region of the response surface.
Ene I Ette, Hui-May Chu, Christopher J Godfrey

Pharm Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis